▲ Peaking
Health
Alzheimer's: BCG vaccine may reshape brain immune response
New clinical trial data suggests the BCG tuberculosis vaccine may reduce Alzheimer's risk by reprogramming the brain's immune environment.
2 trends tracked about this subject — the full history, oldest to newest below.
New clinical trial data suggests the BCG tuberculosis vaccine may reduce Alzheimer's risk by reprogramming the brain's immune environment.
Researchers are testing a dual-targeting GPNMB CAR-T cell therapy to treat aggressive glioblastoma and its supporting immune cells.